Epigenetics, heritability and longitudinal analysis

© 2018 The Author(s). Background: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenot...

Full description

Bibliographic Details
Main Authors: Nustad, H., Almeida, M., Canty, A., Leblanc, M., Page, C., Melton, Phillip
Format: Journal Article
Published: BioMed Central 2018
Online Access:http://hdl.handle.net/20.500.11937/70996
_version_ 1848762361404456960
author Nustad, H.
Almeida, M.
Canty, A.
Leblanc, M.
Page, C.
Melton, Phillip
author_facet Nustad, H.
Almeida, M.
Canty, A.
Leblanc, M.
Page, C.
Melton, Phillip
author_sort Nustad, H.
building Curtin Institutional Repository
collection Online Access
description © 2018 The Author(s). Background: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenotypic and epigenetic data. All contributions used the GAW20 real data set and employed either linear mixed effect (LME) models or marginal models through generalized estimating equations (GEE). These contributions were subdivided into 3 categories: (a) quality control (QC) methods for DNA methylation data; (b) heritability estimates pretreatment and posttreatment with fenofibrate; and (c) impact of drug response pretreatment and posttreatment with fenofibrate on DNA methylation and blood lipids. Results: Two contributions addressed QC and identified large statistical differences with pretreatment and posttreatment DNA methylation, possibly a result of batch effects. Two contributions compared epigenome-wide heritability estimates pretreatment and posttreatment, with one employing a Bayesian LME and the other using a variance-component LME. Density curves comparing these studies indicated these heritability estimates were similar. Another contribution used a variance-component LME to depict the proportion of heritability resulting from a genetic and shared environment. By including environmental exposures as random effects, the authors found heritability estimates became more stable but not significantly different. Two contributions investigated treatment response. One estimated drug-associated methylation effects on triglyceride levels as the response, and identified 11 significant cytosine-phosphate-guanine (CpG) sites with or without adjusting for high-density lipoprotein. The second contribution performed weighted gene coexpression network analysis and identified 6 significant modules of at least 30 CpG sites, including 3 modules with topological differences pretreatment and posttreatment. Conclusions: Four conclusions from this GAW20 working group are: (a) QC measures are an important consideration for EWAS studies that are investigating multiple time points or repeated measurements; (b) application of heritability estimates between time points for individual CpG sites is a useful QC measure for DNA methylation studies; (c) drug intervention demonstrated strong epigenome-wide DNA methylation patterns across the 2 time points; and (d) new statistical methods are required to account for the environmental contributions of DNA methylation across time. These contributions demonstrate numerous opportunities exist for the analysis of longitudinal data in future epigenetic studies.
first_indexed 2025-11-14T10:46:21Z
format Journal Article
id curtin-20.500.11937-70996
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:46:21Z
publishDate 2018
publisher BioMed Central
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-709962021-01-08T07:54:27Z Epigenetics, heritability and longitudinal analysis Nustad, H. Almeida, M. Canty, A. Leblanc, M. Page, C. Melton, Phillip © 2018 The Author(s). Background: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenotypic and epigenetic data. All contributions used the GAW20 real data set and employed either linear mixed effect (LME) models or marginal models through generalized estimating equations (GEE). These contributions were subdivided into 3 categories: (a) quality control (QC) methods for DNA methylation data; (b) heritability estimates pretreatment and posttreatment with fenofibrate; and (c) impact of drug response pretreatment and posttreatment with fenofibrate on DNA methylation and blood lipids. Results: Two contributions addressed QC and identified large statistical differences with pretreatment and posttreatment DNA methylation, possibly a result of batch effects. Two contributions compared epigenome-wide heritability estimates pretreatment and posttreatment, with one employing a Bayesian LME and the other using a variance-component LME. Density curves comparing these studies indicated these heritability estimates were similar. Another contribution used a variance-component LME to depict the proportion of heritability resulting from a genetic and shared environment. By including environmental exposures as random effects, the authors found heritability estimates became more stable but not significantly different. Two contributions investigated treatment response. One estimated drug-associated methylation effects on triglyceride levels as the response, and identified 11 significant cytosine-phosphate-guanine (CpG) sites with or without adjusting for high-density lipoprotein. The second contribution performed weighted gene coexpression network analysis and identified 6 significant modules of at least 30 CpG sites, including 3 modules with topological differences pretreatment and posttreatment. Conclusions: Four conclusions from this GAW20 working group are: (a) QC measures are an important consideration for EWAS studies that are investigating multiple time points or repeated measurements; (b) application of heritability estimates between time points for individual CpG sites is a useful QC measure for DNA methylation studies; (c) drug intervention demonstrated strong epigenome-wide DNA methylation patterns across the 2 time points; and (d) new statistical methods are required to account for the environmental contributions of DNA methylation across time. These contributions demonstrate numerous opportunities exist for the analysis of longitudinal data in future epigenetic studies. 2018 Journal Article http://hdl.handle.net/20.500.11937/70996 10.1186/s12863-018-0648-1 http://creativecommons.org/licenses/by/4.0/ BioMed Central fulltext
spellingShingle Nustad, H.
Almeida, M.
Canty, A.
Leblanc, M.
Page, C.
Melton, Phillip
Epigenetics, heritability and longitudinal analysis
title Epigenetics, heritability and longitudinal analysis
title_full Epigenetics, heritability and longitudinal analysis
title_fullStr Epigenetics, heritability and longitudinal analysis
title_full_unstemmed Epigenetics, heritability and longitudinal analysis
title_short Epigenetics, heritability and longitudinal analysis
title_sort epigenetics, heritability and longitudinal analysis
url http://hdl.handle.net/20.500.11937/70996